Application of a Serum Protein Signature for Pancreatic Cancer to Separate Cases from Controls in a Pancreatic Surveillance Cohort

BACKGROUND: Pancreatic cancer (PC) surveillance is currently offered to individuals with a genetic predisposition to PC, but routinely used radiological screening modalities are not entirely reliable in detecting early-stage PC or its precursor lesions. We recently identified a discriminating PC bio...

Descrición completa

Detalles Bibliográficos

Principais autores:	Thomas P. Potjer, Bart J. Mertens, Simone Nicolardi, Yuri E. M van der Burgt, Bert. A. Bonsing, Wilma E. Mesker, Rob A. E. M Tollenaar, Hans F. A Vasen
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2016-06-01
Series:	Translational Oncology
Acceso en liña:	http://www.sciencedirect.com/science/article/pii/S1936523315300711
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!